Wilson Karen J
SEC-identified person · CIK 1267490 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Serina Therapeutics, Inc. SER | Director | filed 2025 - 2026 |
| Connect Biopharma Holdings Ltd CNTB | Director | filed 2026 - 2026 |
| Lava Therapeutics NV LVTX | Director | filed 2025 - 2025 |
| Elicio Therapeutics, Inc. ELTX | Director | filed 2021 - 2025 |
| Vaxart, Inc. VXRT | Director | filed 2020 - 2021 |
| Jazz Pharmaceuticals plc JAZZ | VP, Finance & PAO | filed 2011 - 2019 |
| Protein Design Labs INC/DE pdli | VP of Finance & PAO | filed 2009 - 2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.